Falk Schwendicke1, Fredrik Brouwer2, Michael Stolpe3. 1. Department of Operative and Preventive Dentistry, Charité-Universitätsmedizin Berlin, Berlin, Germany. Electronic address: falk.schwendicke@charite.de. 2. Department of Operative and Preventive Dentistry, Charité-Universitätsmedizin Berlin, Berlin, Germany. 3. Kiel Institute for the World Economy, Kiel, Germany.
Abstract
INTRODUCTION: Recent evidence finds mineral trioxide aggregate (MTA) more effective than calcium hydroxide (CH) for direct pulp capping (DPC). The present study assessed the cost-effectiveness of MTA versus CH for DPC using a model-based simulation approach. METHODS: A mixed public/private payer perspective in the context of German health care was adopted. We modeled a permanent molar with a vital asymptomatic, exposed pulp treated via DPC with either MTA or CH. The tooth was followed over the lifetime of a 20-year-old patient using Markov models. Transition probabilities were obtained from systematically and nonsystematically collected data. The primary health outcome was tooth retention time. Costs for DPC were estimated via microcosting. Required personnel time for application was estimated using a survey among German specialized and general dentists. Material expenses were calculated based on market prices in 2015. All other costs were derived from public and private item fee catalogues. Uncertainty was introduced via probabilistic and univariate sensitivity analyses. RESULTS: DPC using MTA was both more effective and less costly (52 years retention, lifetime costs = 1368 Euro) than CH (49 years, 1527 Euro). Regardless of a payer's willingness to pay, DPC with MTA had the higher probability of being cost-effective. The identified ranking was not affected by parameter or structural uncertainty or heterogeneity. CONCLUSIONS: MTA was more cost-effective than CH for DPC despite higher initial treatment costs because expensive retreatments were avoided. Our estimates apply only on the basis of current evidence and within the chosen health care setting. From a payer's perspective, MTA should be used for DPC.
INTRODUCTION: Recent evidence finds mineral trioxide aggregate (MTA) more effective than calcium hydroxide (CH) for direct pulp capping (DPC). The present study assessed the cost-effectiveness of MTA versus CH for DPC using a model-based simulation approach. METHODS: A mixed public/private payer perspective in the context of German health care was adopted. We modeled a permanent molar with a vital asymptomatic, exposed pulp treated via DPC with either MTA or CH. The tooth was followed over the lifetime of a 20-year-old patient using Markov models. Transition probabilities were obtained from systematically and nonsystematically collected data. The primary health outcome was tooth retention time. Costs for DPC were estimated via microcosting. Required personnel time for application was estimated using a survey among German specialized and general dentists. Material expenses were calculated based on market prices in 2015. All other costs were derived from public and private item fee catalogues. Uncertainty was introduced via probabilistic and univariate sensitivity analyses. RESULTS:DPC using MTA was both more effective and less costly (52 years retention, lifetime costs = 1368 Euro) than CH (49 years, 1527 Euro). Regardless of a payer's willingness to pay, DPC with MTA had the higher probability of being cost-effective. The identified ranking was not affected by parameter or structural uncertainty or heterogeneity. CONCLUSIONS: MTA was more cost-effective than CH for DPC despite higher initial treatment costs because expensive retreatments were avoided. Our estimates apply only on the basis of current evidence and within the chosen health care setting. From a payer's perspective, MTA should be used for DPC.
Authors: Arthur Dias Galarça; Wellington Luiz de Oliveira Da Rosa; Tiago Machado Da Silva; Giana da Silveira Lima; Neftalí Lenin Villarreal Carreño; Thiago Machado Pereira; Orlando Aguirre Guedes; Alvaro Henrique Borges; Adriana Fernandes da Silva; Evandro Piva Journal: Biomed Res Int Date: 2018-11-27 Impact factor: 3.411
Authors: Wei Qin; Qi-Ting Huang; Michael D Weir; Zhi Song; Ashraf F Fouad; Zheng-Mei Lin; Liang Zhao; Hockin H K Xu Journal: Stem Cells Int Date: 2017-09-14 Impact factor: 5.443
Authors: Julia Guerrero-Gironés; Antonia Alcaina-Lorente; Clara Ortiz-Ruiz; Eduardo Ortiz-Ruiz; María P Pecci-Lloret; Francisco Javier Rodríguez-Lozano; Carlos M Martínez; Antonio José Ortiz-Ruiz Journal: Int J Environ Res Public Health Date: 2020-02-06 Impact factor: 3.390